Show simple item record

dc.contributor.authorMöller, Gabriele
dc.contributor.authorTemml, Veronika
dc.contributor.authorCala Peralta, Antonio 
dc.contributor.authorGruet, Océane
dc.contributor.authorRichomme, Pascal
dc.contributor.authorSeraphin, Denis
dc.contributor.authorViault, Guillaume
dc.contributor.authorKraus, Luisa
dc.contributor.authorHuber-Cantonati, Petra
dc.contributor.authorSchopfhauser, Elisabeth
dc.contributor.authorPachmayr, Johanna
dc.contributor.authorTokarz, Janina
dc.contributor.authorSchuster, Daniela
dc.contributor.authorHelesbeux, Jean-Jacques
dc.contributor.authorAllen Dyar, Kenneth
dc.contributor.otherQuímica Orgánicaes_ES
dc.date.accessioned2025-01-31T09:58:56Z
dc.date.available2025-01-31T09:58:56Z
dc.date.issued2022-01-21
dc.identifier.issn2218-1989
dc.identifier.urihttp://hdl.handle.net/10498/35222
dc.description.abstractNaturally occurring substances are valuable resources for drug development. In this respect, chalcones are known to be antiproliferative agents against prostate cancer cell lines through various mechanisms or targets. Based on the literature and preliminary results, we aimed to study and optimise the efficiency of a series of chalcones to inhibit androgen-converting AKR1C3, known to promote prostate cancer. A total of 12 chalcones with different substitution patterns were synthesised. Structure–activity relationships associated with these modifications on AKR1C3 inhibition were analysed by performing enzymatic assays and docking simulations. In addition, the selectivity and cytotoxicity of the compounds were assessed. In enzymatic assays, C-6′ hydroxylated derivatives were more active than C-6′ methoxylated derivatives. In contrast, C-4 methylation increased activity over C-4 hydroxylation. Docking results supported these findings with the most active compounds fitting nicely in the binding site and exhibiting strong interactions with key amino acid residues. The most effective inhibitors were not cytotoxic for HEK293T cells and selective for 17β-hydroxysteroid dehydrogenases not primarily involved in steroid hormone metabolism. Nevertheless, they inhibited several enzymes of the steroid metabolism pathways. Favourable substitutions that enhanced AKR1C3 inhibition of chalcones were identified. This study paves the way to further develop compounds from this series or related flavonoids with improved inhibitory activity against AKR1C3.es_ES
dc.formatapplication/pdfes_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.sourceMetabolites - 2022, Vol. 12, n. 2 pp. 99es_ES
dc.subjectchalconees_ES
dc.subjectaldo-keto reductasees_ES
dc.subjectcanceres_ES
dc.subjectAKR1C3es_ES
dc.subject17β-hydroxysteroid dehydrogenasees_ES
dc.subject3α-hydroxysteroid dehydrogenasees_ES
dc.subjectstructure-activity relationshipes_ES
dc.titleAnalogues of Natural Chalcones as Efficient Inhibitors of AKR1C3es_ES
dc.typejournal articlees_ES
dc.identifier.urlhttps://www.mdpi.com/2218-1989/12/2/99
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.3390/metabo12020099
dc.type.hasVersionVoRes_ES


Files in this item

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
This work is under a Creative Commons License Attribution-NonCommercial-NoDerivatives 4.0 Internacional